Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

Probable Person-to-Person Transmission of Avian Influenza A (H5N1)

Kumnuan Ungchusak, Prasert Auewarakul, Scott F. Dowell et al. · New England Journal of Medicine · 2005 · 868 citations

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

John J. Treanor, James D. Campbell, Kenneth M. Zangwill et al. · New England Journal of Medicine · 2006 · 696 citations · Full text

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

Honglin Chen, Gavin J. D. Smith, Kangsheng Li et al. · Proceedings of the National Academy of Sciences · 2006 · 629 citations · Full text

Vaccination, Viral Evolution, Southeast Asia +13

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

Karl G. Nicholson, Anthony Colegate, Audino Podda et al. · The Lancet · 2001 · 442 citations

Vaccination, Vaccine Safety, Cross-protection +10

Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

Iain Stephenson, Roberto Bugarini, Karl G. Nicholson et al. · The Journal of Infectious Diseases · 2005 · 281 citations · Full text

Vaccination, Cross-protection, Vaccine Development +13